Bradley Gehrs to RNA, Messenger
This is a "connection" page, showing publications Bradley Gehrs has written about RNA, Messenger.
Connection Strength
0.018
-
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition. Mol Cancer Ther. 2009 Jul; 8(7):1867-77.
Score: 0.018